This page summarises a third-party laboratory report that we hold. The report itself was produced for a sample submitted by another party and is not a Strata-manufactured document. We publish the verified figures and state plainly what the report does and does not show. Email or WhatsApp us if you need the report reference for your own due diligence.
Verified report details
- Task number
- Janoshik Analytical #203223
- Reported sample
- Batched sample labelled in the R10 product line
- Reported by
- A third-party supplier, not Strata Peptides
- Analysis date
- 10 July 2026
- Analyte
- Retatrutide
- Content per vial
- 11.53 mg (repeat 11.53 mg)
- Purity
- 99.240% (repeat 99.498%)
- Test requested
- Common GLP-1 peptide blind test (semaglutide, tirzepatide, retatrutide)
What this report does not show
The report describes the sample that was submitted to the laboratory. It does not prove that any specific Strata lot was tested, and it does not make this an approved medicine. Ask us for the lot code on your vial and for documentation matching that lot.
Why this page shows figures rather than an image
We publish the recorded figures, the task number and the analysis date as text, so that you can read exactly what the report covers and what it does not. If you need the paperwork for the batch you are buying, ask us on WhatsApp and we will send what we hold for that lot.
Our purity guarantee
If your vial tests below 99% purity at an independent laboratory, we refund the order in full. That promise is ours and does not depend on this reference report. See current terms.